5 results  1 of 1 

1 PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI–Resistant Metastatic Clear Cell Renal Cell Carcinoma
Se Un Jeong, Hee Sang Hwang, Ja-Min Park, Sun Young Yoon, Su-Jin Shin, Heounjeong Go, Jae-Lyun Lee, Gowun Jeong, Yong Mee Cho
Cancer Res Treat.2023;55(1):231-244.   Published online 2022 March 2     DOI: http://dx.doi.org/10.4143/crt.2021.1526
      
2 Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies
Elizabeth Anne Richardson, Ben Ho, Annie Huang
J Korean Neurosurg Soc.2018;61(3):302-311.   Published online 2018 May 1     DOI: http://dx.doi.org/10.3340/jkns.2018.0061
      
3 Interferon treatment for Japanese patients with favorable-risk metastatic renal cell carcinoma in the era of targeted therapy
Tomokazu Sazuka, Naoki Nihei, Kazuyoshi Nakamura, Shinichi Sakamoto, Satoshi Fukasawa, Atsushi Komaru, Takeshi Ueda, Tatsuo Igarashi, Tomohiko Ichikawa
Korean J Urol.2015;56(3):205-211.   Published online 2015 March 3     DOI: http://dx.doi.org/10.4111/kju.2015.56.3.205
      
4 Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors
Sei-Hoon Yang
Tuberc Respir Dis.2013;75(5):188-198.   Published online 2013 November 29     DOI: http://dx.doi.org/10.4046/trd.2013.75.5.188
      
5 The Role of Focal Adhesion Kinase in the TGF-β-Induced Myofibroblast Transdifferentiation of Human Tenon's Fibroblasts
Samin Hong, Jong Bok Lee, Yoko Iizuka, Yoo Kyung Song, Gong Je Seong, Sueng-Han Han
Korean J Ophthalmol.2012;26(1):45-48.   Published online 2012 January 14     DOI: http://dx.doi.org/10.3341/kjo.2012.26.1.45
      

 1 of 1